AI Drug Discovery Market Has Projected Growth
The sector reached a valuation of nearly $20 billion in 2025 and is expected to expand rapidly over the next decade.
Updated on Oct. 1, 2026 in Artificial Intelligence
Live Poll
Do you believe artificial intelligence will significantly improve the speed and effectiveness of drug discovery?
The global market for artificial intelligence in drug discovery reached a value of $19.89 billion in 2025. Projections indicate this sector will grow to $160.49 billion by 2035.
Why it matters
This rapid market expansion highlights an industry-wide acceleration in using machine learning to streamline pharmaceutical development. The anticipated trajectory suggests a significant shift in how new therapeutic compounds are identified and validated.
The market is forecast to maintain a compound annual growth rate of 23.22% through 2035. This growth projection is based on the integration of AI-driven computational modeling into traditional drug development pipelines.
The players
Towards Healthcare
An analytical research organization that specializes in forecasting economic trends within the global healthcare and pharmaceutical industries.
The details
The AI drug discovery process utilizes algorithmic modeling to simulate molecular interactions and identify potential therapeutic candidates faster than traditional laboratory methods. These computational systems analyze vast datasets of biological information to predict how chemical structures will bind to specific protein targets, a process essential for drug optimization. As these digital workflows gain adoption, they replace iterative manual trial-and-error procedures.
Timeline
2025: The global AI in drug discovery market value reached $19.89 billion.
2035: The market is projected to reach a value of $160.49 billion.
The Tech Race
This growth forecast follows the pattern set by Towards Healthcare's 2025-2035 global AI drug discovery market report. It signals a move toward high-volume computational workflows in pharmaceutical R&D.
This transition will likely shift pharmaceutical innovation toward more automated, computationally intensive R&D cycles. Industry professionals and stakeholders should monitor this 23.22% annual growth to identify changes in drug development timelines.
The takeaway
The sector's growth reflects a long-term transition toward digital-first drug development. Observers should track annual market updates to see if actual growth aligns with the projected 23.22% annual rate.
Further reading
For more on the systems driving this shift, visit Artificial Intelligence.
Source note: This article includes information reported by Star Local.
Live Poll
Do you believe artificial intelligence will significantly improve the speed and effectiveness of drug discovery?
